drugset / Trial / NCT00060268
Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors
NaSingle-groupTreatment
Summary
RATIONALE: Photodynamic therapy uses light and drugs that make tumor cells more sensitive to light to kill tumor cells. Photosensitizing drugs such as HPPH are absorbed by tumor cells and, when exposed to light, become active and kill the tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of photodynamic therapy with HPPH in treating patients who have obstructive esophageal tumors.
Timeline
- Start
- 1997-01
- Primary completion
- 2003-09
- Completion
- 2004-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 2-(1-Hydroxyethyl)-2-Devinylpyropheophorbide-a | Unknown | — | Intravenous |